An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 9 Jan 2021]

 

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets
During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online “immuno-analytics” resource that…
Authors: Daniel Ward, Matthew Higgins, Jody E. Phelan, Martin L. Hibberd, Susana Campino and Taane G. Clark
Citation: Genome Medicine 2021 13:4
Content type: Database
Published on: 7 January 2021